Gennova submits phase 2 trial data of mRNA vaccine for DGCI approval

The mRNA vaccine may be the first vaccine to be introduced in India specifically designed against the Delta and Omicron variant of COVID-19.

source https://www.jagranjosh.com/current-affairs/gennova-submits-phase-2-trial-data-of-mrna-vaccine-for-dgci-approval-1642406399-1